• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, March 17, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

ACO to sell Melbourne HQ and build ‘purpose-led facility’

by Staff Writer
February 6, 2026
in Business, Company updates & acquisitions, Local, News, Ophthalmic insights
Reading Time: 2 mins read
A A
ACO is planning to sell its headquarters and build a new facility over the next two to five years. Image: ACO.

ACO is planning to sell its headquarters and build a new facility over the next two to five years. Image: ACO.

Share on FacebookShare on Twitter

The Australian College of Optometry (ACO) has announced it is selling its Carlton, Melbourne, headquarters and relocating to a right-sized, purpose-led facility.

An ACO media release said the move would “better support our communities, and strengthen clinical care, research, and education”.

The move follows an independent Victorian Eyecare Service (VES) review conducted in 2024 that outlined where ACO patients were, the importance of locating close to them to deliver quality care, and the need to expand satellite clinic rooms and outreach services – initiatives the organisation was actively advancing.

ACO CEO Pete Haydon said the decision to sell followed many years of consideration and analysis.

“Over the past 20 years, our organisation has undergone a quiet but significant transformation, and the way we train, research, and deliver care to our patients has changed,” he said.

ACO began as a teaching clinic in 1940 and quickly developed a strong public health ethos. In the 1950s, the organisation received its first Government grant, helping extend optometry care to underserved communities in Victoria.

When full-time undergraduate education shifted from ACO to the University of Melbourne in 2005, the organisation’s focus turned to providing clinical placements for Australian optometry students, and targeted professional development.

The release said that in 2023, a strategic decision to shift the focus from neuroscience to clinical research was made to align with the ACO’s public health mission.

“After two decades of change, we now only need about one-third of the space we currently have,” Haydon said.

“We no longer require the extensive teaching, education, or laboratory spaces we once did, and these areas have proven costly and difficult to repurpose, leaving many of them unused and deteriorating.

“Today, we stand as leaders in public health, but our headquarters has not kept pace. It is underutilised, increasingly costly to maintain, and in need of a major renovation.”

Haydon said funds from the sale would be reinvested in a more suitable and fit-for-purpose premises within Melbourne’s city fringe.

“Reinvesting in a modern premises is a practical step to secure our future – helping us deliver lasting impact, support our communities, and strengthen clinical care, research, and education for generations to come,” he said.

“We acknowledge the significance that our headquarters holds for many in the profession who began their careers at ACO when we were a full-time training facility. While this chapter remains an integral part of the ACO story, it concluded a long time ago.

“We want to honour where we’ve come from, while responding to the changing needs of our patients and the profession.”

A two- to five‑year timeframe has been put on the building sale and relocation.

Related Posts

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Dry eye can be exacerbated or even present for the first time after cataract surgery. Image: Pormezz/stock.adobe.com

Dry Eye Society announces Melbourne launch event

by Staff Writer
March 16, 2026

The Dry Eye Society (DES) has announced its official Melbourne launch event, bringing together eye care professionals with a shared interest...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited